Gene expression analysis in these two highly homogeneous groups of patients indicates the potential role of IGF1 as one of the key signalling pathways involved in the development of intrinsic chemotherapy resistance in ovarian cancer. The gene discussed is IGF1; the disease is ovarian carcinoma.